Incidence of thromboembolism in patients with melanoma on immune checkpoint inhibitor therapy and its adverse association with survival

BACKGROUND: Thromboembolism (TE) in cancer significantly contributes to morbidity and mortality. Little is known about the incidence of arterial TE (ATE) and venous TE (VTE) in patients with melanoma on immune checkpoint inhibitor (ICI) therapy. METHODS: We conducted a retrospective cohort study of...

Descripción completa

Detalles Bibliográficos
Autores principales: Sussman, Tamara A, Li, Hong, Hobbs, Brian, Funchain, Pauline, McCrae, Keith R, Khorana, Alok A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7805375/
https://www.ncbi.nlm.nih.gov/pubmed/33436486
http://dx.doi.org/10.1136/jitc-2020-001719

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7805375/
https://www.ncbi.nlm.nih.gov/pubmed/33436486
http://dx.doi.org/10.1136/jitc-2020-001719

Ejemplares similares